Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer

NCT00642759 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: carboplatin
DRUG: Nab-paclitaxel
DRUG: Bevacizumab

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]
[object Object]